There are 412 resources available
110MO - Statin use and early breast cancer survival: A Danish population-based cohort study using an emulated target trial approach
Presenter: Sixten Harborg
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
What room for immunotherapy for non-triple negative breast cancer?
Presenter: Sung-Bae Kim
Session: Current and future standards for immunotherapies for breast cancer
Resources:
Slides
Webcast
AI in breast cancer screening and diagnosis
Presenter: Fiona Gilbert
Session: The growing role of artificial intelligence (AI) in breast cancer care
Resources:
Slides
Webcast
111MO - Tailored dose-dense versus standard adjuvant chemotherapy for high-risk early breast cancer: Efficacy outcomes and key subgroups after 10 years of follow-up in the randomized phase III PANTHER trial
Presenter: Theodoros Foukakis
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Where to go from here: Combinations and beyond
Presenter: Sibylle Loibl
Session: Current and future standards for immunotherapies for breast cancer
Resources:
Slides
Webcast
Can AI allow us to better analyse large scale clinical data?
Presenter: Arsela Prelaj
Session: The growing role of artificial intelligence (AI) in breast cancer care
Resources:
Slides
Webcast
Q&A and discussion
Session: Current and future standards for immunotherapies for breast cancer
Resources:
Webcast
Invited Discussant LBA1, 110MO and 111MO
Presenter: Elzbieta Senkus-Konefka
Session: Mini Oral session 2
Resources:
Slides
Webcast
Conclusions and clinical perspectives
Session: The growing role of artificial intelligence (AI) in breast cancer care
Resources:
Webcast
268MO - Safety of vaginal estrogen therapy after early-stage breast cancer: A nationwide population-based target trial emulation
Presenter: Elise Dumas
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast